GRAL
GRAIL, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$122.42
+3.91%Leverage
- Debt / equity
- 0.04x
- Net debt / equity
- 0.01x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.24x
- Net debt / EBITDA
- -0.10x
Liquidity & coverage
- Current ratio
- 10.95x
- Quick ratio
- 10.74x
- Cash ratio
- 10.31x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $831.2M
Cash & dividend
- FCF / debt
- -3.23x
- Cash flow / debt
- -3.23x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026